Company profile
Lentitek
Lentitek Ltd is a UK company with status active founded in 2019 based in Scotland.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
RP01CS01 | Transaction MzUyNjQ3MjQ4MWFkaXF6a2N4
Published 19 Jun 2026 13:29
CS01 | Transaction MzQ3MjY0MjA1OGFkaXF6a2N4 | Paper/PDF filed
Published 23 Jun 2026 23:03
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQ2MTU0MjIxOWFkaXF6a2N4 | Paper/PDF filed
Published 19 Jun 2026 22:45
PSC04 | Transaction MzQ1NjA3ODU0OGFkaXF6a2N4
Published 22 Feb 2025 05:46
SH01 | Transaction MzQ1NjA3ODQ4NmFkaXF6a2N4
Published 22 Feb 2025 05:41
SH01 | Transaction MzQ1NjA3ODIyN2FkaXF6a2N4
Published 22 Feb 2025 05:17
AP01 | Transaction MzQzMTYyNDQzNGFkaXF6a2N4
Published 08 Aug 2024 13:35
Company registered at Companies House
1 Sep 2024 to 28 Feb 2026
Chimeric antigen receptor (CAR) T-cell immunotherapies have transformed patient outcomes for blood-borne cancers. Most vector for commercial CAR-T is lentivirus, which is used to modify T-cells _ex vivo_ prior to their reinfusion into the patient. However, high manufacturing and treatment costs and rising safety concerns threaten to derail the advanced th...
